Division 2.1 Information of the Approved Body regarding changes and new informationF1

Any change in relation to processes of sourcing, collection, handling, processing and inactivation or elimination and any new information on TSE risk collected by the manufacturer and relevant for the medical device that could modify the result of the manufacturer’s risk assessment must be transmitted to the F2approved body and, where applicable, needs to be approved by the approved body prior to its implementation.